Comparative analysis of first-generation epidermal growth factor receptor inhibitors combined with chemotherapy versus third-generation epidermal growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer: a systematic

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-08-14
DOI
https://doi.org/10.3389/fphar.2025.1586332
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative analysis of first-generation epidermal growth factor receptor inhibitors combined with chemotherapy versus third-generation epidermal growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer: a systematic

Zhixin Yu, Huijuan Qiu, Yixin Zhou, Honglin Zhu et al.
Frontiers in Pharmacology
Lung Cancer Treatments and Mutations
article

Comparative analysis of first-generation epidermal growth factor receptor inhibitors combined with chemotherapy versus third-generation epidermal growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer: a systematic

Zhixin Yu, Huijuan Qiu, Yixin Zhou, Honglin Zhu, Shaodong Hong, C. Jason Liang, Siyan Peng
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Sun Yat-sen University (CN), Sun Yat-sen University Cancer Center (CN)
Openalex Percentile: Top 66%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.